Vaccination in Individuals with Multiple Sclerosis--Part II/Multipl Skleroz Tanili Bireylerde Asilama--Bolum II

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient...

Full description

Saved in:
Bibliographic Details
Published inTürk nöroloji dergisi Vol. 29; no. 2; p. 85
Main Authors Cinar, Bilge Piri, Tuncer, Asli, Bilge, Nuray, Bunul, Sena Destan, Gozubatik-Celik, Rabia Gokcen, Ciftci, Eda Derle, Genc, Gencer, Karaman, Bedriye, Kilic, Ahmet Kasim, Sariteke, Alp, Seferoglu, Meral, Sivaci, Ali Ozhan, Tiftikcioglu, Bedile Irem, Tunc, Abdulkadir, Uncu, Gulgun, Yavas, Irfan, Yetkin, Mehmet Fatih, Efendi, Husnu, Siva, Aksel
Format Journal Article
LanguageEnglish
Published Galenos Yayinevi Tic. Ltd 01.06.2023
Subjects
Care and treatment
Cross infection
Diagnosis
Dosage and administration
Influenza vaccines
Multiple sclerosis
Nosocomial infections
Prevention
Risk factors
Turkey
Online AccessGet full text

Cover

More Information
Summary:Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient. Since vaccination can be performed at any stage of life, immune system activity should be reviewed in patients with MS except where it is characteristic of the vaccine. In this review, the applications of different vaccines in patients with MS are discussed in two separate sections (part 1 was published in the previous issue). Keywords: Multiple sclerosis, vaccination, safety Multipl skleroz (MS) merkezi sinir sisteminin otoimmun ve demiyelinizan hastaligidir. Kronik bir hastalik olup bireye ait tum diger saglik ve yasamsal sureclerin degerlendirilmesinde hastalik seyri, hastanin kullandigi ilaclari goz onune alarak karar vermek gereklidir. Asilama, cocukluktan yetiskinlige yasamin her doneminde uygulanabildigi icin MS tanili bireylerde de her bir asinin ozelligi disinda hastanin immun sistem etkinligi mutlaka gozden gecirilmelidir. Bu derlemede MS tanili bireylerde farkli asilarin uygulamalari tartisilacak olup, farkli iki bolum halinde yayinlanmasi planlanmistir. Anahtar Kelimeler: Multipl skleroz, asilama, guvenlik
ISSN:1301-062X
1309-2545
DOI:10.4274/tnd.2023.16984